FluBlok, a recombinant hemagglutinin influenza vaccine
Abstract FluBlok, a recombinant trivalent hemagglutinin (HA) vaccine produced in insect cell culture using the baculovirus expression system, provides an attractive alternative to the current egg‐based trivalent inactivated influenza vaccine (TIV) manufacturing process. FluBlok contains three time...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Blackwell Publishing Ltd
2008
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634115/ |